Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing heart and lung dose reconstruction in breast cancer radiotherapy using publicly available out-of-field dose profiles.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Correction: Fatigue among adult survivors of childhood cancer: findings from the French Childhood Cancer Survivor Study.

Journal of cancer survivorship : research and practice·2026
Same author

Dose-dependent cerebrovascular impact of pediatric brain radiotherapy revealed by advanced MRI: the AVARTHEC study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Fatigue among adult survivors of childhood cancer: findings from the French Childhood Cancer Survivor Study.

Journal of cancer survivorship : research and practice·2026
Same author

The Effects of Physical Therapy in the Rehabilitation of Motor Delays in Children with Down Syndrome: A Systematic Review.

Journal of clinical medicine·2026
Same author

Adaptive radiotherapy in paediatric patients: a SIOP Europe ROWG survey on practice patterns across Europe.

The British journal of radiology·2026

Related Experiment Video

Updated: May 21, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Thyroid adenomas after solid cancer in childhood.

Nadia Haddy1, Chiraz El-Fayech, Catherine Guibout

  • 1Radiation Epidemiology Group, INSERM, Villejuif, France.

International Journal of Radiation Oncology, Biology, Physics
|June 8, 2012
PubMed
Summary

Childhood cancer survivors exposed to radiation therapy have an increased risk of developing thyroid adenomas. Chemotherapy can modify this risk, especially with higher radiation doses.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Related Experiment Videos

Last Updated: May 21, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Area of Science:

  • Pediatric Oncology
  • Endocrinology
  • Radiation Oncology

Background:

  • Childhood cancer survivors are at increased risk for long-term health issues.
  • Thyroid adenomas are a potential late effect of cancer treatment, particularly radiation therapy.
  • Limited data exists on the specific risk factors for thyroid adenomas in this population.

Purpose of the Study:

  • To evaluate the association between radiation dose to the thyroid and chemotherapy exposure with the risk of thyroid adenoma in childhood cancer survivors.
  • To quantify the excess relative risk of thyroid adenoma per Gray of radiation dose.
  • To investigate the modifying effect of chemotherapy on the radiation dose-response relationship.

Main Methods:

  • A cohort of 3254 childhood cancer survivors treated before 1986 in France was studied.
  • Thyroid radiation doses were reconstructed based on treatment records.
  • Follow-up data was analyzed to identify cases of thyroid adenoma.

Main Results:

  • Thyroid adenoma risk increased with radiation dose up to a few Gray, then plateaued and declined.
  • Chemotherapy alone slightly increased risk but reduced the dose-response slope.
  • Excess relative risk per Gray was higher for younger patients and those receiving fewer chemotherapy drugs.

Conclusions:

  • The risk pattern for thyroid adenoma following childhood cancer radiation therapy resembles that of thyroid carcinoma.
  • Radiation dose is a significant risk factor, with chemotherapy potentially modifying the risk.
  • Age at radiation exposure is also a critical factor in adenoma development.